-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q1 2025.
- Cytek Biosciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2025 was -$15M, a 39.5% decline year-over-year.
- Cytek Biosciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2025 was -$24.8M, a 6.26% increase year-over-year.
- Cytek Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$20.5M, a 26.3% increase from 2023.
- Cytek Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$27.8M, a 1444% decline from 2022.
- Cytek Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$1.8M, a 120% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)